<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">282</journal-id><journal-id journal-id-type="pmc-domain">brjpharm</journal-id><journal-title-group><journal-title>British Journal of Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0007-1188</issn><issn pub-type="epub">1476-5381</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC1572014</article-id><article-id pub-id-type="pmcid-ver">PMC1572014.1</article-id><article-id pub-id-type="pmcaid">1572014</article-id><article-id pub-id-type="pmcaiid">1572014</article-id><article-id pub-id-type="pmid">10780965</article-id><article-id pub-id-type="doi">10.1038/sj.bjp.0703260</article-id><article-id pub-id-type="pii">0703260</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Papers</subject></subj-group></article-categories><title-group><article-title>Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Marchand</surname><given-names initials="S">Sandrine</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pariat</surname><given-names initials="C">Claudine</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bouquet</surname><given-names initials="S">Serge</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Courtois</surname><given-names initials="P">Philippe</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Couet</surname><given-names initials="W">William</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label><sup>1</sup>UPRES EA 1223, Facult&#233; de M&#233;decine &amp; Pharmacie, 34, rue du Jardin des Plantes, BP 199, 86005 Poitiers Cedex, France</aff><author-notes><corresp id="caf1"><label>*</label>Author for correspondence: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:William.Couet@campus.univ-poitiers.fr">William.Couet@campus.univ-poitiers.fr</email></corresp></author-notes><pub-date pub-type="ppub"><month>04</month><year>2000</year></pub-date><volume>129</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">134835</issue-id><fpage>1609</fpage><lpage>1616</lpage><history><date date-type="received"><day>22</day><month>09</month><year>1999</year></date><date date-type="rev-recd"><day>10</day><month>01</month><year>2000</year></date><date date-type="accepted"><day>27</day><month>01</month><year>2000</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2001</year></date></event><event event-type="pmc-live"><date><day>10</day><month>01</month><year>2008</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-05-06 18:25:11.180"><day>06</day><month>05</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright 2000, Nature Publishing Group</copyright-statement><copyright-year>2000</copyright-year><copyright-holder>Nature Publishing Group</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="129-0703260a.pdf"/><abstract><p>
<list list-type="order"><list-item><p>Fluoroquinolones (FQs) are associated with a low incidence of central nervous system (CNS) side effects, possibly leading to convulsions, especially when co-administered with nonsteroidal anti-inflammatory drugs (NSAIDS). Although the <italic>in vivo</italic> pro-convulsant activity of NSAIDS is essentially unknown, the convulsant potential of FQs is traditionally evaluated by <italic>in vitro</italic> &#947;-aminobutyric acid (GABA) binding experiments in the presence of 4-biphenyl acetic acid (BPAA), the active metabolite of fenbufen.</p></list-item><list-item><p>The aim of this study was therefore to investigate the BPAA-norfloxacin convulsant interaction <italic>in vivo</italic>.</p></list-item><list-item><p>Male Sprague-Dawley rats (<italic>n</italic>=27) were given BPAA orally, at various doses 1&#8201;h before norfloxacin infusion, which was maintained until the onset of maximal seizures, when cerebrospinal fluid (CSF) and plasma samples were collected for analysis.</p></list-item><list-item><p>An inhibitory E<sub>max</sub> effect model with a baseline effect parameter was fitted to the norfloxacin versus BPAA concentrations in the CSF, previously shown to be part of the biophase. This model includes three parameters: the concentrations of norfloxacin in the absence of BPAA (C<sub>CSF0, Nor</sub>), and when BPAA concentration tends toward infinity (C<sub>CSFbase, Nor</sub>), and the BPAA concentration for which half of the maximal effect is observed (C<sub>CSF50, BPAA</sub>). The maximal proconvulsant effect of BPAA is given by the C<sub>CSF0, Nor</sub> / C<sub>CSFbase, Nor</sub> ratio, estimated to approximately 6 in this study.</p></list-item><list-item><p>Derived models were developed in plasma to account for the non-linear CSF diffusion of norfloxacin and protein binding of BPAA.</p></list-item><list-item><p>In conclusion this study has shown that the convulsant interaction between norfloxacin and BPAA in rats, can be adequately characterized by modelling of the CSF concentrations of the two drugs at the onset of activity, following their administration in various proportions.</p></list-item></list></p></abstract><kwd-group><kwd>Fluoroquinolones</kwd><kwd>nonstero&#239;dal antiinflammatories</kwd><kwd>biphenyl acetic acid</kwd><kwd>seizures</kwd><kwd>inhibitory E<sub>max</sub> effect model</kwd><kwd>non-linear CSF diffusion</kwd><kwd>saturable protein binding</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>